Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
131.19 | -10.02% | 3.18% | 332,278.86 | 2.35% | -19.03% |
|
NYSE:PFE
Pfizer
|
28.64 | 8.42% | 38.65% | 162,291.22 | 5.87% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
89.17 | 19.33% | 38.3% | 111,472.92 | 4.22% | 8.19% |
|
LSE:GSK
GSK
|
17.75 | 7.44% | 23.26% | 72,385.16 | 3.27% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.74% | 72.08% | 89,253.22 | 5.45% | 13.54% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4130.00 | 0% | 0% | 6,479,696.8 | 4.75% | 0% |
|
NasdaqGS:INCY
Incyte
|
57.10 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
NasdaqGM:OMER
Omeros
|
3.45 | 0% | 0% | 241.63 | 0% | 0% |
|
NasdaqCM:XFOR
X4 Pharmaceuticals
|
0.93 | 0% | 0% | 183.05 | 0% | 0% |
|
ASX:DXB
Dimerix
|
0.38 | 0% | 0% | 159.38 | 0% | 0% |
|
NasdaqGS:IFRX
InflaRx N.V.
|
1.63 | 0% | 0% | 85.38 | 0% | 0% |
|
TASE:BLRX
BioLineRx
|
0.16 | 0% | 0% | 302.07 | 0% | 0% |
|
NasdaqCM:AKTX
Akari Therapeutics, Plc
|
1.52 | 0% | 0% | 9.39 | 0% | 0% |
